This mirrors our recently reported results in CML where by simultaneously modulating p53-driven apoptosis and MYC-driven differentiation we were able to selectively extinguish the leukaemic stem cell.33 No significant effect on colony size was obtained in any condition. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.